Source: Eur Respir J 2008; 31: 773-782
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Reuter S., Heinz A., Sieren M., Wiewrodt R., Gelfand E. W., Stassen M., Buhl R., Taube C.. Mast cell-derived tumour necrosis factor is essential for allergic airway disease. Eur Respir J 2008; 31: 773-782

Member's Comments

No comment yet.

Related content which might interest you: Cytokines in asthma Source: Eur Respir J 2001; 18: 24S-33S Year: 2001 Tumour necrosis factor gene polymorphisms and childhood wheezing Source: Eur Respir J 2005; 26: 637-646 Year: 2005 Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro Source: Eur Respir J 2002; 20: 1449-1456 Year: 2002 Increased immunoreactivity of stromal cell-derived factor-1 and angiogenesis in asthma Source: Eur Respir J 2003; 21: 804-809 Year: 2003 Alveolar macrophages are the main source for tumour necrosis factor-α in patients with sarcoidosis Source: Eur Respir J 2003; 21: 421-428 Year: 2003 Cytokines in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 50S-59S Year: 2001 Vascular endothelial growth factor (VEGF) , a specific marker of angiogenesis, is increased in asthmatic airways following allergen challenge Source: Eur Respir J 2004; 24: Suppl. 48, 227s Year: 2004 Enhancement of neutrophil function by the bronchial epithelium stimulated by epidermal growth factor Source: Eur Respir J 2008; 31: 714-724 Year: 2008 Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats Source: Eur Respir J 2007; 30: 31-39 Year: 2007 Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases Source: Eur Respir J 2008; 32: 1068-1081 Year: 2008 Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids Source: Eur Respir J 2001; 18: 115-121 Year: 2001 Increased vascular endothelial growth factor in acute eosinophilic pneumonia Source: Eur Respir J 2003; 21: 774-778 Year: 2003 Tumor necrosis factor α in chronic pulmonary diseases of children Source: Eur Respir J 2002; 20: Suppl. 38, 193s Year: 2002 Inhaled antibodies: targeting tumour necrosis factor receptor 1 and thymic stromal lymphopoietin Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments Year: 2019 The epidermal growth factor receptor mediates allergic airway remodelling in the rat Source: Eur Respir J 2008; 32: 1213-1223 Year: 2008 Epidermal growth factor in the lungs of infants developing chronic lung disease Source: Eur Respir J 2001; 18: 796-800 Year: 2001 Inhibition of proliferation of lung cancer cells by CD40 signaling through tumor necrosis factor I Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Imbalance between vascular endothelial growth factor and endostatin in emphysema Source: Eur Respir J 2003 Oct 01;22(4):609-612 Year: 2003 Evaluation levels of pro-inflammatory cytokines tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma in lung cancer complicated with metastatic pleurisy Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001 The contribution of transforming growth factor-β and epidermal growth factor signalling to airway remodelling in chronic asthma Source: Eur Respir J 2006; 27: 208-229 Year: 2006